×

Equipment and Services Health Care Equipment and Supplies

  • WASHINGTON, Dec 27- Healthcare company Abbott Laboratories has won U.S. antitrust approval for its proposed $25 billion acquisition of medical device maker St. Jude Medical Inc, the U.S. Federal Trade Commission said on Tuesday. Jude's vascular closure device and Abbott's steerable sheath to Japan- based Terumo Corp. In October, Abbott said the companies would...

  • WASHINGTON, Dec 27- Healthcare company Abbott Laboratories has won U.S. antitrust approval for its proposed purchase of medical device maker St. Jude Medical Inc, the U.S. Federal Trade Commission said on Tuesday. Jude's vascular closure device and Abbott's steerable sheath- to Japan- based Terumo Corp..

  • WASHINGTON, Dec 27- Healthcare company Abbott Laboratories has won U.S. antitrust approval for its proposed purchase of medical device maker St. Jude Medical Inc, the Federal Trade Commission said on Tuesday. Abbott has agreed to divest two medical device businesses to settle FTC charges that the $25 billion acquisition of St.

  • The FDA released the 30- page guidance as the agency investigates claims from a short-selling firm and security researchers that heart devices from St. The FDA has been grappling with such issues for several years in response to a surge in research on potentially life- threatening security bugs in medical devices from so-called "white hat" hackers looking to...

  • WASHINGTON, Dec 22- U.S. antitrust enforcers are poised to approve health care company Abbott Laboratories' purchase of medical device maker St. It was not immediately known what conditions the FTC would require but Abbott said in October the companies would sell some of their medical devices to Japan- based Terumo Corp for about $1.12 billion as a step toward...

  • Under New Mexico regulations, healthcare facilities must report a suspected outbreak of C. difficile to the state Health Department within 24 hours. But Casa Maria staff did not contact authorities until March 4, 2014, according to the Health Department report on its investigation of the outbreak, a copy of which was obtained by Reuters. When a Health...

  • Dec 21- U.S. stocks fell on Wednesday, with healthcare and real estate shares losing ground a day after the Nasdaq Composite and the Dow Jones Industrial Average hit record highs. U.S. stocks have rallied since the Nov. 8 election, with the Dow up 9 percent and the S&P 500 gaining 6 percent on bets that President-elect Donald Trump's plans for deregulation and...

  • MADRID, Dec 15- Spain's Grifols, which said late on Wednesday it would buy U.S. medical device maker Hologic Inc's side of their joint venture blood screening business for $1.85 billion, expects to refinance its debt once the deal is completed, its Chief Financing Officer said on Thursday. On Wednesday Grifols said it would pay $1.85 billion in cash for a plant in...

  • Dec 14- Spain's Grifols SA, which develops plasma protein therapies, said it would buy U.S. medical device maker Hologic Inc's interest in their blood screening joint venture for $1.85 billion in cash. Grifols, which owns the customer-facing activities of the venture, said the acquired assets comprise a plant in San Diego, California as well as development...

  • PARIS, Dec 13- Artificial heart-maker Carmat is' rather confident' on the resumption of implants in the final-stage clinical trial for its artificial hearts, its chief executive Stephane Piat said on Tuesday. France's national drugs agency, ANSM, ordered Carmat to suspend further implants earlier this month following the death of a patient in October.

  • PARIS, Dec 13- Artificial heart-maker Carmat is' rather confident' on the resumption of implants in the final-stage clinical trial for its artificial hearts, its chief executive Stephane Piat said on Tuesday. France's national drugs agency, ANSM, ordered Carmat to suspend further implants earlier this month following the death of a patient in October.

  • Stryker CEO: Medical tax is a 'job and innovation killer'

    Kevin Lobo, Stryker chairman & CEO, talks about some of the company's newest technology in hard tissue robotics and why reform is needed in Obamacare.

  • WARSAW, Indiana/ WASHINGTON, Dec 9- When Donald Trump takes over as president on Jan. 20, one of the first business tax breaks he delivers is likely to go to the U.S. medical device industry and companies like Mark Throdahl's. The chief executive of OrthoPediatrics Corp, based in northern Indiana, said his company has been able to hire more workers since the temporary...

  • Although legal experts think J&J faces an uphill battle, both they and investors believe the Texas jury's penalty, the largest product liability verdict so far this year, is unlikely to stand. It is the second large verdict against J&J in the Pinnacle implant litigation, which has been consolidated before U.S. District Court Judge Edward Kinkeade in Texas.

  • Dec 2- A federal appeals court on Friday threw out an antitrust verdict that ordered medical device maker Becton Dickinson and Co to pay rival Retractable Technologies Inc $340 million in damages over its marketing of safety syringes. The 5th U.S. Circuit Court of Appeals in New Orleans called Retractable's claim that Becton violated the Sherman Act by trying...

  • PARIS, Dec 1- Shares in artificial heart maker Carmat fell more than 13 percent on Thursday after France's national drugs agency ordered it to suspend further implants in a second test phase following the death of a patient in October. Carmat shares were down by 13.19 percent at 29.01 euros in end-session trading, wiping some 26 million euros off the company's...

  • PARIS, Dec 1- Shares in artificial heart maker Carmat slumped on Thursday after France's national drugs agency ordered it to suspend further implants following the death of a patient in October. Carmat shares were down by 12.4 percent at 29.55 euros in mid-session trading, wiping some 26 million euros off the company's stock market value.

  • PARIS, Dec 1- Shares in artificial heart maker Carmat slumped on Thursday after France's national drugs agency ordered it to suspend further implants following the death of a patient in October. Carmat shares were down by 18.5 percent at 27.50 euros in morning trading, with around 40 million euros wiped off its stock market value. Carmat Chief Executive...

  • PARIS, Nov 30- France's national drugs agency said on Wednesday it had ordered artificial heart maker Carmat to suspend further implants after a fifth patient died in October. A spokeswoman for the drugs agency said that it had requested further information from the company following the patient's death, which was first reported by Europe 1 radio.

  • J&J warns of cybersecurity issue with insulin pump

    CNBC's Meg Tirrell reports the latest details surrounding Johnson & Johnson and the cyber hack of one of the company's medical devices. Jay Radcliffe, Rapid7 senior security consultant, weighs in.